Editorial Policy & Evidence Standards

OncoDermatologyGuides adheres to rigorous standards of medical transparency, accuracy, and peer-reviewed guideline synthesis.

Evidence Sources

All clinical algorithms, steroid tapers, and diagnostic parameters are sourced from consensus guidelines published by:

• Multinational Association of Supportive Care in Cancer (MASCC) — Skin Toxicity Study Group
• European Society for Medical Oncology (ESMO) — Dermatologic irAE Guidelines
• American Society of Clinical Oncology (ASCO) — Management of Cutaneous Toxicities
• British Association of Dermatologists (BAD) — SJS/TEN Clinical Protocols

Commercial Independence

OncoDermatologyGuides maintains complete editorial independence and accepts no commercial sponsorships from pharmaceutical or dermatological product manufacturers that influence our clinical recommendations.